New
Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
253280 ETF · RISE Healthcare ETF
The 253280 Exchange Traded Fund (ETF) is provided by RISE ETF. It is built to track an index: FnGuide Inc Healthcare Index. The 253280 ETF provides physical exposure, so by buying it you actually own parts of all the 43 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Today at 12:00 AM UTC
LIVE
CLOSED
This fund is part ofAPAC Blended Cap1M perf.-3.15%
Last price
â‚©16,710
1M perf.
-9.85%
1M flows
+€1M
AuM
€6.6M
E/R
0.4%
Rating
Not rated
ESG Consensus®
253280
â‚©16,710
Performance & flows
Segment for quartile rank
January 6, 2026 → April 6, 2026
Create a free account to view the flows graph
253280
â‚©16,564.76
-5.81%
APAC Blended Cap
-2.03%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -9.85%  | -5.81% | +29.55%  | +49.90%  | +8.35% | -4.87% | -4.87% | -1.62% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
4/6/2026
â‚©16,564.76
1D NAV change
-1.27%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
43
Inception date
9/23/2016
Jurisdiction
South Korea
Distribution
Congo, The Democratic Republic of the
Democratic People's Republic of Korea
Iran, Islamic Republic Of
South Korea
Macedonia, The Former Yugoslav Republic of
Legal structure
Open-end Investment Trust
Base currency
KRW
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The ETF tracks FnGuide Healthcare Index and aims to deliver similar performance while maintaining minimal tracking error.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
143860
1M perf.
-10.63%
E/R
0.4%
266420
1M perf.
-10.74%
E/R
0.45%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -5.81% | +29.55% | +49.90% | +8.35% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise
Exposure
Countries
Republic of Korea
98.04%
Unavailable
1.96%
Sectors
Health Care
89.79%
Consumer Discretionary
5.98%
Unavailable
3.46%
Other
0.77%
Diversification
Total weight of top 15 holdings out of 43
Top 15 holdings
Data as of February 28, 2026
CELLTRION
SAM CHUN DANG PH
SAMSUNG BIOLOGICS CO LTD
ABL BIO
ALTEOGEN INC
YUHAN
HLB
LEGOCHEM BIOSCIENCES
Create a free account to view top holdings
HANMI PHARM
SK BIOPHARMACEUTICALS CO LTD
PHARMARESEARCH CO LTD
HAN ALL BIOPHARM
ST PHARM
L&C BIO
CELLTRION PHARM
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise
Sustainability
Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise
Replication
Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of March 31, 2026
Tracking error
Tracking difference
Replication information
Index
FnGuide Inc Healthcare Index - KRW
Index ticker
FNGDHEAL Index
Index dividend policy
PI
Replication method
Replication model
More replication analysis are available, exclusively in Trackinsight Enterprise
Issuer
RISE ETF
RISE ETF ID Card
Number of funds
54
Total AuM
€7.27B
Expense ratio range
0.012% - 0.65%
Average expense ratio
0.2536%
Top 5 funds by RISE ETF
| AuM | ||
|---|---|---|
148020 | RISE 200 ETF | €1.82B |
455890 | RISE Money Market Active ETF | €1.39B |
477080 | RISE CD RateActive(SYNTH) ETF | €864M |
479520 | RISE KOFR Active(SYNTH) ETF | €468M |
475720 | RISE 200 Weekly Covered Call ETF | €444M |
Frequently asked questions about 253280
What does RISE Healthcare ETF, 253280, invest in?
253280 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.
Which benchmark or index does 253280 replicate?
253280 tracks the FnGuide Inc Healthcare Index - KRW, through a full replication replication method.
What is the Total Expense ratio (TER) of 253280?
253280 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
When was 253280 launched?
253280 was introduced to the market on September 23, 2016. It trades on Congo, The Democratic Republic of the, among other exchanges
Who is the ETF issuer of 253280?
RISE Healthcare ETF, 253280, is provided by RISE ETF. Learn more about RISE ETF here.
What is the current assets under management (AUM) of 253280?
253280 oversees €6.6M in assets as of April 6, 2026.
How has 253280 performed lately?
Based on data from April 6, 2026, 253280 returned -9.85% over the past month, -5.81% over the last three months and -1.62% year-to-date.
What are the latest inflows or outflows for 253280?
As of April 6, 2026, 253280 recorded net flows of +€1.1M over the last month and +€1.1M year-to-date.
Does 253280 distribute dividends?
253280 follows a distributing dividend policy, meaning it pays out income to investors. As of April 6, 2026, its 12-month trailing yield was 0.12%.
What are the main country or region exposures of 253280?
As of February 28, 2026, 253280 has significant geographic allocations in Republic of Korea.
In which sector or theme does 253280 invest in?
As of February 28, 2026, 253280 focuses largely on Health Care and Consumer Discretionary.
How many securities does 253280 hold and how diversified is it?
As of February 28, 2026, 253280 holds 43 positions in its portfolio, with 79.00% of assets concentrated in its top 15 holdings.
What are the main positions in 253280?
As of February 28, 2026, 253280 top three holdings include CELLTRION, SAM CHUN DANG PH and SAMSUNG BIOLOGICS CO LTD.
What is the base currency of 253280?
The base currency of 253280 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
